drugset / Trial / NCT01955512

Effect of Clopidogrel on Allergen Challenge in Asthma

NCT01955512

Phase 2 Completed 24 enrolled University of Southampton
RandomizedParallel-groupDouble-blindBasic science

Summary

In asthma, breathing in an allergen, such as house dust mite induces inflammation in the airways. This process appears to involve an interaction between two different sorts of blood cells, platelets and white blood cells via a receptor called the P2Y12 receptor. The purpose of this study is to determine whether the drug clopidogrel which blocks the P2Y12 receptor on platelets, reduces inflammation following breathing in house dust mite in people with mild asthma.

Timeline

Start
2013-05
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Clopidogrel Small molecule 75 mg

Indications